Literature DB >> 7742821

Guidelines for the management of community-acquired pneumonia in adults. Italian Society of Pneumology. Italian Society of Respiratory Medicine. Italian Society of Chemotherapy.

G Gialdroni Grassi1, L Bianchi.   

Abstract

In general practice Community-acquired Pneumonia (CAP) is most often treated on an empyrical basis. Therefore, it is of the utmost importance to know the epidemiology of respiratory pathogens in order to give some guidelines for the empirical management of CAP. At present in cases of mild and moderate severity, ampicillin or amoxycillin, preferably in association with sulbactam and clavulanic acid respectively, and macrolides are the antibiotics of first choice. The latter can be an alternative to beta-lactams when Legionella, Mycoplasma and Chlamydia are the suspected etiologic agents or when patients are allergic to penicillins. They can also be used in combination with beta-lactams when etiological diagnosis is extremely uncertain. The course and severity of the disease, a chest radiograph, the results of microbiological and other laboratory examinations will determine the choice of further antibiotic treatment and other therapeutic measures, if necessary.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7742821

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  8 in total

1.  Reasons for choice of antibiotic for the empirical treatment of CAP by Canadian infectious disease physicians.

Authors:  J Pendergrast; T Marrie
Journal:  Can J Infect Dis       Date:  1999-09

2.  Guidelinitis: A new syndrome?

Authors:  B L Johnston; J M Conly
Journal:  Can J Infect Dis       Date:  2000-11

3.  Predicting death from pneumonia.

Authors:  M Woodhead
Journal:  Thorax       Date:  1996-10       Impact factor: 9.139

4.  Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia.

Authors:  Bryan Z Wilson; Antonio Anzueto; Marcos I Restrepo; Mary Jo V Pugh; Eric M Mortensen
Journal:  Crit Care Med       Date:  2012-08       Impact factor: 7.598

Review 5.  Adherence to guidelines for community-acquired pneumonia: does it decrease cost of care?

Authors:  Patricia D Brown
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

6.  Switch therapy in hospitalized patients with community-acquired pneumonia: tigecycline vs. levofloxacin.

Authors:  Julio A Ramirez; Angel C Cooper; Timothy Wiemken; David Gardiner; Timothy Babinchak
Journal:  BMC Infect Dis       Date:  2012-07-19       Impact factor: 3.090

7.  The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.

Authors:  Eric M Mortensen; Marcos I Restrepo; Antonio Anzueto; Jacqueline Pugh
Journal:  Crit Care       Date:  2005-12-06       Impact factor: 9.097

8.  Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016).

Authors:  Xiaoguang He; Mingyu Xie; Siping Li; Junqin Ye; Qi Peng; Qiang Ma; Xiaomei Lu; Baimao Zhong
Journal:  BMC Infect Dis       Date:  2017-09-11       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.